@MilesCcc @ELRIG_SCIENCE Find out more about the event here: https://t.co/OHhxDJN5aN ...

Join our Chief Scientific Officer, @MilesCcc, at @ELRIG_SCIENCE Drug Discovery 2025: Festival of Life Science in Liverpool, on 21 October at 14:00 BST, where he will explore how @IsomorphicLabs integrates its advanced structure prediction models with bespoke machine learning approaches to binding affinity and ADMET optimisation – unlocking chemical spaces traditional methods struggle to reach. ...

@caseymross @STAT Find out more about the event here: https://t.co/1QH9MzAsko ...

Our Chief Medical Officer, Dr. Ben Wolf, will be joining @caseymross from 11:20 - 11:45am EDT on 16 October at the @STAT Summit to talk about why our mission to solve all disease inspired him to bring his 20 years of drug development experience to Isomorphic Labs. https://t.co/yT9DIHUeEd ...

Event Details - Isomorphic Labs' Chief AI Officer and Chief Scientific Officer will participate in a virtual fireside chat at the 2025 Endpoints AI Day on October 14, from 11:00-11:40am EDT [1] AI and Drug Discovery - The discussion will focus on the intersection of AI and drug discovery at Isomorphic Labs [1] - Isomorphic Labs' drug design engine enables operation across various therapeutic areas and drug modalities [1]

@maxjaderberg @MilesCcc @AndrewE_Dunn Sign up now: https://t.co/m2Z329hdl8 ...

Event Details - Isomorphic Labs 的两位高管 Max Jaderberg (Chief AI Officer) 和 MilesCcc (Chief Scientific Officer) 将于 2026 年 10 月 14 日参加 Endpoints AI Day 的炉边谈话 [1] - 炉边谈话时间为美国东部时间上午 11:00 至 11:40，共计 40 分钟 [1] Focus of Discussion - Isomorphic Labs 将深入探讨 AI 如何与药物发现相结合 [1] - Isomorphic Labs 的药物设计引擎使其能够在多个治疗领域和药物模式中运营 [1]

@SergeiIakhnin @BioTechX_ Find out more: https://t.co/4rOADZjcHx ...

In less than a week, our CTO @SergeiIakhnin will open @BioTechX_ EU with his keynote: "AI Models from Atoms to Humans: the Era of Rational In Silico Drug Design."Join him in Basel on October 6th, at 9am CEST to explore how advanced AI is already reinventing drug discovery, and his vision for a future where it accelerates breakthroughs that move us closer to solving all disease. ...

Last week, our Chief Scientific Officer @MilesCcc participated in @BioCentury Grand Rounds Europe in Cambridge, UK. During his "Small Compounds, Big Potential" panel, Miles discussed how technology is accelerating and reducing the cost of molecule creation, and the collaborative efforts of academia, start-ups, and industry in advancing drug development. ...